Full name
BIORESEARCH GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
21.20.Z - Manufacture of medicines and other pharmaceutical products
70.2 - Management consultancy activities
72.1 - Research and experimental development on natural sciences and engineering
77.11.Z - Rental and leasing of cars and light motor vehicles
82.30.Z - Organisation of conventions and trade shows
85.60.Z - Educational support activities
86.1 - Hospital activities
86.2 - Medical and dental practice activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,9 | 1 | 0 | -95,4 |
EBITDA | 1,9 | 1,1 | -0 | -100,9 |
Short time liabilities | 0,3 | 0,4 | 0,4 | 15,4 |
Equity capital | 2 | 2,9 | 2,9 | 1,7 |
Operating profit (EBIT) | 1,9 | 1,1 | -0 | -101,2 |
Assets | 2,9 | 3,6 | 3,8 | 5,9 |
Net profit (loss) | 1,8 | 0,9 | 0 | -96,6 |
Cash | 1,8 | 0,9 | 0,6 | -32,3 |
Net income from sale | 3,6 | 6,1 | 4,6 | -24,2 |
Liabilities and provisions for liabilities | 1 | 0,7 | 0,9 | 22,5 |
Working assets | 2,9 | 3,6 | 3,8 | 6 |
Depreciation | 0 | 0 | 0 | -37,9 |
% | % | % | p.p. | |
Profitability of capital | 91,8 | 32,1 | 1,1 | -31 |
Equity capital to total assets | 66,6 | 79,6 | 76,4 | -3,2 |
Gross profit margin | 53,7 | 16,8 | 1 | -15,8 |
EBITDA Margin | 54,3 | 17,3 | -0,2 | -17,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 28 | 22 | 34 | 12 |
Current financial liquidity indicator | 2.985863208770752 | 4.886659145355225 | 4.230152606964111 | -0,7 |
Net dept to EBITDA | -0.9105530977249146 | -0.7950504422187805 | 47.37531280517578 | 48,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane